Weight Management Consultations
Rate Your Plate
Wellness Blood Profile-$
Bone Density Screenings
Smoking Cessation Readiness
Neck & Back Health
Cancer Risk Assessments
Shane Farritor, a Nebraska Engineering professor with two startup companies, leads a free series on How to Innovate. Gain concrete, actionable tools you can use to foster innovation in all you do. Free sessions are Tuesdays and Thursdays, 12:30-1:30 p.m. in Jorgensen 110 OR 6-7 p.m. at NET Studios, 1800 N. 33rd St.
Oct. 18 - Seminar #1: We Need Your Gift
Oct. 20 - Seminar #2: Little Bets
Nov. 1 - Seminar #3: Brainstorming and Other Thinkertoys
Nov. 3 - Seminar #4: Orbiting The Giant Hairball
Nov. 15 - Seminar #5: Where Good Ideas Come From
Nov. 22 - Seminar #6: What in the Hell are You Talking About
For session descriptions see http://shanefarritor.com/innovation-seminars/
Questions about the Innovation Seminar Series: Email email@example.com.
The Chancellor's University Safety Committee offers an Open Forum on Campus Safety twice a year during its regular meeting. If you have questions or issues relating to campus safety anytime, e-mail Chair Colleen Huls at firstname.lastname@example.org or call at 402-472-2131.
Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University. Jean-Christophe (Chris) Rochet obtained his PhD in the Department of Biochemistry at the University of Alberta. He then worked as a post-doctoral fellow in the laboratory of Dr. Peter Lansbury at the Center for Neurologic Diseases at Harvard Medical School. In 2002 he became a faculty member in the department of Medicinal Chemistry and Molecular Pharmacology at Purdue University. The overall goals of his research program are to understand how protein aggregation and mitochondrial dysfunction contribute to Parkinson’s disease (PD). Dr. Rochet’s group has addressed these problems by exploring the structural and functional properties of PD-related gene products (e.g. alpha-synuclein, DJ-1) and by characterizing the neuroprotective effects of molecules with antioxidant activity, including various polyphenols. Ultimately the insights from these studies may stimulate the development of new strategies to treat patients with PD and other neurodegenerative disorders.